Attorneys and recall consultants predict a sharp spike in drug recalls reported during the third quarter after the US Food and Drug Administration restarted domestic inspections, targeting firms making adulterated COVID-19 products or making fraudulent claims.
These observations were made in medical waste services company Stericycle, Inc.’s most recent quarterly recalls report, which compiles recall...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?